Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
The Training Science Trials Ledger follows ClinicalTrials.gov studies of exercise and training interventions, with training and population families, randomization and sponsor flags and completion horizons, drawn from the public ClinicalTrials.gov API and refreshed weekly. Entries summarize registered studies; no medical advice is given or implied.
- Start Date
- 10/31/2026
- Title
- Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
- Status
- NOT_YET_RECRUITING
- Training Family
- exercise (general)
- Population Family
- clinical population
- Is Recruiting
- true